UPB vs WAT · rev $2.4M vs P/E 32, rev $1.65B
Upstream Bio, Inc. (UPB) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
UPB currently screens at market cap $407.3M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the UPB and WAT stock pages for the full models.
Not investment advice.